TABLE 2

Optimized transitions and parameters of the analytes

AnalytesMRM TransitionDeclustering PotentialCollision EnergyPolarity
m/zVeV
Acetaminophen152.0 → 110.06024ESI +
4-hydroxytolbutamide287.0→188.06018ESI +
7-hydroxycoumarin163.0 → 107.09030ESI +
2-hydroxybupropion256.3 → 238.06018ESI +
6α-hydroxypaclitaxel870.5 → 286.29020ESI +
4′-hydroxydiclofenac312.0 → 266.07019ESI +
5-hydroxyomeprazole362.0→196.06042ESI +
4′-hydroxymephenytoin233.0 → 190.05517ESI −
1’-hydroxybufuralol278.0 → 186.010026ESI +
Dextrorphan258.5 → 157.018050ESI +
6-hydroxychlorzoxazone184.0 → 120.05525ESI −
1′-hydroxymidazolam342.0 → 203.013037ESI +
4′-hydroxymidazolam342.0 → 234.013032ESI +
6β-hydroxytestosterone305.0 → 269.06021ESI +
6-hydroxychlorzoxazone184.0 → 120.05525ESI −
Mephenamine (IS)270.0 → 181.06013ESI +
  • ESI +, Electrospray ionization Positive; ESI −, Electrospray ionization Negative; IS, internal standard; MRM, Multiple reaction monitoring.